AMRN Related Press Releases

May 9, 2013 04:05 PM Photo Release -- Amarin Reports First Quarter 2013 Financial Results and Provides Update on Operations

May 3, 2013 04:00 PM Amarin to Report First Quarter 2013 Results and Host Conference Call on May 9, 2013

Apr 30, 2013 06:00 AM Amarin Announces Approval of Supplemental New Drug Application for BASF as Additional Vascepa(R) Active Pharmaceutical Ingredient Supplier

Apr 23, 2013 06:00 AM Amarin Announces FDA Acceptance of Supplemental New Drug Application (sNDA) for Vascepa(R) for the Treatment of Patients With High Triglycerides (>200 mg/dL and <500 mg/dL) With Mixed Dyslipidem

Apr 18, 2013 06:00 AM Amarin Announces Approval of Supplemental New Drug Application for Chemport as Additional Vascepa(R) Active Pharmaceutical Ingredient Supplier

Apr 8, 2013 06:00 AM Amarin Announces New Clinical Data Showing Significant Reductions in Apolipoprotein C-III Levels in MARINE and ANCHOR Studies of Vascepa(R)